Medical Devices Business Capabilities Model

A detailed, multi-level capability map for the Medical Devices sector, covering 320+ business capabilities organized across three hierarchical levels. Medical device manufacturing is governed end to end by FDA approval pathways, ISO 13485 quality requirements, and post-market surveillance obligations that don't exist in general industrial manufacturing.

Why a capability model, not a prompt

A generic AI prompt for "medical device capabilities" tends to return a standard manufacturing-and-quality list — manage production, manage quality, manage supply chain — with "medical device" pasted on top, because it doesn't actually know the regulatory structure that governs this industry. Getting a device to market runs through a specific approval pathway — 510(k) premarket notification for lower-risk devices, or full premarket approval (PMA) with clinical evidence for higher-risk ones — which is a fundamentally different gate than a generic "launch product" capability, and the quality system underneath it has to conform to ISO 13485, the medical-device-specific quality standard that imposes design-control and risk-management capabilities well beyond generic ISO 9001. Every device instance also carries a unique device identifier (UDI) that has to be traceable across its lifecycle, which is a materially different capability than a generic serial-number or lot-tracking function. And unlike most manufacturing, the obligation doesn't end at shipment: post-market surveillance, complaint handling, and adverse-event reporting continue for as long as the device is in the field, which makes post-market capability a core, ongoing capability domain rather than a warranty afterthought. A model built without knowledge of 510(k)/PMA pathways, ISO 13485, UDI, and post-market surveillance isn't really a medical device capability model — it's a generic manufacturing model wearing a medical device label.

What's Inside

• Capability Map — 320+ capabilities across Level 1 (strategic), Level 2 (tactical), and Level 3 (operational), in PowerPoint, Word, and Excel
• Capability Definitions — Clear descriptions at the most granular level, covering regulatory, quality, and post-market capabilities alike
• Capability KPIs — Measurable indicators at Level 2 to assess maturity and performance

How Teams Use It

• Map product-development capabilities to the correct regulatory pathway — 510(k) vs. PMA — instead of a single generic "launch product" capability
• Assess design-control and risk-management capabilities against ISO 13485 and ISO 14971 requirements ahead of a quality-system audit or QMS consolidation
• Scope UDI traceability capabilities across the full device lifecycle when planning a track-and-trace or serialization systems investment
• Baseline post-market surveillance, complaint-handling, and adverse-event reporting capabilities separately from general customer service when planning regulatory or quality systems

Who It's For

Regulatory affairs leaders, quality and risk-management directors, R&D and product-development leads, and enterprise architects at medical device manufacturers and diagnostics companies.